Scientists have discovered that a common type of bacteria that causes infections in hospitals can break down biodegradable ...

Fungal infections caused by multi-drug resistant (MDR) pathogens pose a growing threat to human health. The identification of new and safe antifungals with novel modes of action is now vital.

APT's platform is based on a growing library of bacteriophages, viruses that infect and kill bacteria, that could be used to treat a range of multi-drug resistant (MDR) pathogens, and the Fund's $ ...

Now, its spent some of that budget on a new antifungal from Scynexis that could tackle an emerging multidrug-resistant (MDR) pathogen. The exclusive licensing deal covers Brexafemme (ibrexafungerp ...

† Alternative diagnostic criteria: ≥1 of parameters 1.2 and ≥1 of parameters 3.4. VAP may be diagnosed by a CPIS ≥6 [28,29]. ‡ Applicable for VAP only. BAL: Bronchoalveolar lavage ...

The rapid rise of multidrug-resistant (MDR) bacteria makes treating bacterial infections increasingly difficult, and the widespread use of antibiotics in agricultural, clinical, and residential ...

TAXIS Pharmaceuticals is developing first-in-class anti-resistance drugs to help re-engage widely prescribed but resistance-prone generic antibiotics to treat patients with multidrug-resistant ...

Biologists from the University of the Philippines - Diliman College of Science are looking into the rapid rise of multidrug-resistant (MDR) bacteria such as salmonella in poultry products. The study ...

In recent years, colistin has attracted considerable interest as an antibiotic for use against MDR strains ... a treatment option against pathogenic bacteria.